Rehmann Capital Advisory Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $56.5K | Buy |
1,081
+47
| +5% | +$2.46K | 0.01% | 583 |
|
|
2019
Q2 | $50K | Buy |
1,034
+778
| +304% | +$37.6K | 0.01% | 835 |
|
|
2019
Q1 | $12.9K | Sell |
256
-196
| -43% | -$9.9K | ﹤0.01% | 1251 |
|
|
2018
Q4 | $26.8K | Buy |
452
+199
| +79% | +$11.8K | ﹤0.01% | 784 |
|
|
2018
Q3 | $16.7K | Buy |
253
+15
| +6% | +$987 | ﹤0.01% | 1180 |
|
|
2018
Q2 | $12K | Sell |
238
-18
| -7% | -$909 | ﹤0.01% | 1276 |
|
|
2018
Q1 | $13K | Buy |
+256
| New | +$13K | ﹤0.01% | 1212 |
|